OTHER PUBLICATIONS & ABSTRACTS
Other Data
Evidence / Other
Clinicopathologic and Molecular Characterization of Low-Grade, Early-Stage, and HER2-Positive Invasive Breast Carcinoma
Publication: American Journal of Clinical Pathology, 2025, Vol. 163, No. 6Authors: Natasha Hunter, MD; Lisa Han, MD; Haley Corbin, MD; Eric Q. Konnick, MD, MS, ; William R. Gwin III, MD; Shaveta Vinayak, MD; Hannah Linden, MD; William Audeh, MD; Lavanya Samraj, MD, MS; Andrea R. Menicucci, PhD; FLEX Investigators Read More
Association of MammaPrint and Clinical Outcomes by Race Among 5000 Individuals With HR+HER2- Early-Stage Breast Cancer Enrolled in FLEX
Publication: ASCO® 2025 Authors: Erin Cobain, Priyanka Sharma, Kent Hoskins, Michael Berry, Gregory Vidal, Jamie Alberty, Nicole Gordon, Harshini Ramaswamy, Nicole Stivers, Andrea Menicucci, William Audeh, Joyce O’Shaughnessy Title: Association of MammaPrint and clinical outcomes by race among 5000 individuals with HR+HER2- early stage breast cancer enrolled in FLEX Read More
High Concordance of 70-Gene Recurrence Risk Signature and 80-Gene Molecular Subtyping Signature Between Core Needle Biopsy and Surgical Resection Specimens in Early-Stage Breast Cancer
Publication: J Surg Oncol. 2022;125:596–602. Authors: Jennifer A. Crozier MD | Julie Barone DO | Pat Whitworth MD |Abraham Cheong MD | Robert Maganini MD | Jose Perez Tamayo MD | Patricia Dauer PhD | Shiyu Wang MS | William Audeh MD | Annuska M. Glas PhD Title: High Read More
Genomic risk classification and whole transcriptome analysis of HR+/HER2- Post-partum breast cancers – A FLEX sub study
Publication: ESMO Breast 2024 Authors: Virginia F. Borges1, Elena Shagisultanova1, Joyce O'Shaughnessy2, Adam Brufsky3, Reshma L. Mahtani4, Kent Hoskins5, Hannah Linden6, Nina D'Abreo7, Sahra Uygun8, Lavanya Samraj8, William Audeh8 University of Colorado Anschutz Medical Campus, Aurora CO 2. Baylor University Medical Center, Dallas, TX 3. University of Pittsburgh Medical Center Read More
Survival Outcomes for Patients With Invasive Lobular Cancer by MammaPrint: Results From the MINDACT Phase III Trial
Publication: European Journal of Cancer 217 (2025) 115222 Authors: O. Metzger Filho, F. Cardoso, C. Poncet, C. Desmedt, S. Linn, J. Wesseling,F. Hilbers, S. Delaloge, J.-Y. Pierga, E. Brain, S. Vrijaldenhoven, P.A. Neijenhuisj, E.J.Th Rutgers, M. Piccart, L.J. van ’t Veerl, G. Viale Title: Survival outcomes for patients with Read More
FLEX: A Real-World Evidence, Full Transcriptome Study in 30,000 Patients With Early-Stage Breast Cancer
Source: San Antonio Breast Cancer Symposium® Authors: Robert Maganini, Ellis Levine, Kent Hoskins, Sarah Thayer, Alfredo Santillan, Sung HoLee, Eduardo Dias, Regina Hampton, Eric Brow Title: FLEX: A Real-World Evidence, Full Transcriptome Study in 30,000 Patients With Early-Stage Breast Cancer Background: The advent of subtype-specific treatments, particularly hormone therapies Read More
Incorporating Immunotherapy in the Management of Early-Stage Estrogen Receptor-Positive Breast Cancer
Publication: ESMO Open - Volume 9 - Issue 11 - 2024 1 Authors: G. Nader-Marta, A. G. Waks, S. M. Tolaney, E. L. Mayer Title: Incorporating immunotherapy in the management of early-stage estrogen receptor-positive breast cancer Abstract Immune checkpoint inhibitors (ICI) have been incorporated into standard treatment regimens for Read More
